EGFR and gastric cancer: Moreover, it was reported that genes involved in the Ras/ERK signaling pathway, such as FGFR2, KRAS, EGFR, ERBB2, and MET, are amplified in a mutually exclusive manner in approximately 40% of GC cases [17].